As of 2025-06-24, the Intrinsic Value of Mycronic AB (publ) (MYCR.ST) is 129.04 SEK. This MYCR.ST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 186.70 SEK, the upside of Mycronic AB (publ) is -30.90%.
The range of the Intrinsic Value is 104.14 - 177.23 SEK
Based on its market price of 186.70 SEK and our intrinsic valuation, Mycronic AB (publ) (MYCR.ST) is overvalued by 30.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 104.14 - 177.23 | 129.04 | -30.9% |
| DCF (Growth 10y) | 124.98 - 208.24 | 153.62 | -17.7% |
| DCF (EBITDA 5y) | 196.22 - 257.50 | 219.14 | 17.4% |
| DCF (EBITDA 10y) | 208.05 - 291.68 | 240.42 | 28.8% |
| Fair Value | 172.28 - 172.28 | 172.28 | -7.72% |
| P/E | 223.84 - 387.33 | 283.80 | 52.0% |
| EV/EBITDA | 181.35 - 253.21 | 211.31 | 13.2% |
| EPV | 73.46 - 93.02 | 83.24 | -55.4% |
| DDM - Stable | 67.81 - 168.95 | 118.38 | -36.6% |
| DDM - Multi | 77.16 - 152.20 | 102.69 | -45.0% |
| Market Cap (mil) | 36,744.43 |
| Beta | 1.21 |
| Outstanding shares (mil) | 196.81 |
| Enterprise Value (mil) | 33,968.43 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.22% |
| Cost of Debt | 4.76% |
| WACC | 9.18% |